scispace - formally typeset
A

Antonios Pantazis

Researcher at University College London

Publications -  40
Citations -  2376

Antonios Pantazis is an academic researcher from University College London. The author has contributed to research in topics: Right ventricular cardiomyopathy & Cardiomyopathy. The author has an hindex of 20, co-authored 32 publications receiving 2153 citations. Previous affiliations of Antonios Pantazis include United States Department of State & University College Hospital.

Papers
More filters
Journal ArticleDOI

Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria?

TL;DR: An unexpectedly high percentage of patients with heart failure fulfilling current echocardiographic criteria for LVNC is demonstrated, which might be explained by a hitherto underestimated cause of heart failure, but the comparison with controls suggests that current diagnostic criteria are too sensitive, particularly in black individuals.
Journal ArticleDOI

Familial Evaluation in Arrhythmogenic Right Ventricular Cardiomyopathy Impact of Genetics and Revised Task Force Criteria

TL;DR: The role of genotyping in familial assessment for arrhythmogenic right ventricular cardiomyopathy was investigated, including the prevalence of mutations in known causal genes, the penetrance and expressivity in genotyped families, and the utility of the 2010 Task Force criteria in clinical diagnosis.
Journal ArticleDOI

Clinical expression of plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathy

TL;DR: New evidence is provided that mutations in the desmosomal plakophilin-2 gene can cause Arrhythmogenic right ventricular cardiomyopathy and the need for a more accurate set of diagnostic criteria for ARVC is highlighted.
Journal ArticleDOI

Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy.

TL;DR: Familial disease is common among infants and children with HCM and that, in most cases, disease is caused by mutations in cardiac sarcomere protein genes, the major implication is that all first-degree relatives of any child diagnosed with H CM should be offered screening.